Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2- Early Breast Cancer Patients

被引:4
|
作者
Li, Shuai [1 ]
Chen, Xiaosong [1 ]
Shen, Kunwei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Comprehens Breast Hlth Ctr, Dept Gen Surg,Sch Med, Shanghai, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
基金
中国国家自然科学基金;
关键词
breast neoplasms; core needle biopsy; surgical sample; Ki-67; change; prognosis; INTERNATIONAL EXPERT CONSENSUS; HER2; STATUS; SURGICAL SPECIMENS; ESTROGEN-RECEPTOR; ENDOCRINE THERAPY; AMERICAN SOCIETY; KI67; EXPRESSION; WOMEN; INDEX; EXCISION;
D O I
10.3389/fsurg.2022.905575
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background; To investigate the association of Ki-67 change pattern after core needle biopsy (CNB) and prognosis in HR+/HER2- early breast cancer patients. Method: Eligible patients were categorized into three groups: Low group, Elevation group, and High group. Chi-square test and logistic regression analysis were used to compare the clinic-pathological characteristics. Kaplan-Meier method was used to estimate the rates of recurrence-free interval (RFI) and breast cancer-specific survival (BCSS), which were compared via the Log-rank test. Cox proportional hazard analysis was performed to investigate independent prognostic factors. Results: A total of 2,858 patients were included: 1,179 (41.3%), 482 (16.9%), and 1,197 (41.8%) patients were classified into the low, elevation, and high groups, respectively. Age, tumor size, histological grade, lymph-vascular invasion (LVI), and ER level status were associated with Ki-67 change pattern after CNB. With a median follow-up of 53.6 months, the estimated 5-year RFI rates for the low group, elevation, and high groups were 96.4%, 95.3% and 90.9%, respectively (P < 0.001). And 5-year BCSS rates were 99.3%, 98.3% and 96.8%, respectively (P = 0.001). Compared with patients in the low group, patients in the high group had significantly worse RFI (hazard ratio [HR] 1.71, 95% confidence interval [CI] 1.16-2.54) in multivariate analysis. Conclusions: Ki-67 change after CNB was associated with prognosis in HR+/HER2- early breast cancer. Patients with Ki-67 high or elevation after CNB had an inferior disease outcome, indicating the necessity of re-evaluating Ki-67 on surgical specimens after CNB.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Patient-reported Quality of Life and Treatment Satisfaction in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
    Wood, Robert
    Mitra, Debanjali
    de Courcy, Jonathan
    Iyer, Shrividya
    CLINICAL THERAPEUTICS, 2017, 39 (08) : 1719 - 1728
  • [32] Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients
    Ge, Wen-kai
    Yang, Ben
    Zuo, Wen-shu
    Zheng, Gang
    Dai, Ying-qi
    Han, Chao
    Yang, Li
    Zheng, Mei-zhu
    THORACIC CANCER, 2015, 6 (01) : 64 - 69
  • [33] Utilizing multimodal ultrasonography in conjunction with serum Ki-67 and HER2 tests for breast cancer detection and prognosis
    Liu, Lei
    Zong, Xiao-Jian
    Wu, Jie
    Li, Jing-Jing
    Yuan, Ping
    Cao, Jian
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2025,
  • [34] Reliability of preoperative core needle biopsy for determing ER, PR, HER2 status and Ki67 expression in invasive breast cancer
    Lakic, T.
    Ivkovic-Kapicl, T.
    Lovrenski, A.
    Sabo, J. Ilic
    Vuckovic-Hardi, L.
    Jelicic, I.
    VIRCHOWS ARCHIV, 2015, 467 : S52 - S52
  • [35] COMPARISON OF HER2 mRNA PCR LEVELS AND IMMUNOHISTOCHEMISTRY (IHC) IN HORMONE RECEPTOR POSITIVE (HR+)/HER2 NEGATIVE (HER2-) EARLY BREAST CANCER
    Tejerina-Peces, Julia
    Amann-Arevalo, Marta
    Ballestin, Pablo
    Gonzalez-Diez, Beatriz
    Paz-Cabezas, Mateo
    Pascual, Alejandro
    de Luna, Alicia
    Garcia-Barberan, Vanesa
    Lopez de Sa, Alfonso
    Garcia-Saenz, Jose Angel
    Moreno, Fernando
    CANCER RESEARCH, 2024, 84 (09)
  • [36] HR+/HER2-乳腺癌患者Ki-67临界值的确定及表达对早期复发转移的影响
    马琴
    厚玉瑾
    高旭彤
    刘新兰
    天津医药, 2021, 49 (12) : 1319 - 1323
  • [37] Comprehensive genomic profiling of advanced HR+/HER2-breast cancer patients using liquid biopsy
    Shao, B.
    Tang, H.
    Liu, X-R.
    Song, G.
    Di, L.
    Xie, F.
    Jia, C.
    Zhang, Y.
    Jia, S.
    Li, H.
    ANNALS OF ONCOLOGY, 2023, 34 : S389 - S389
  • [38] The expression of KI-67 and LEF-1 in patients after breast cancer resection and its effects on patients' prognosis
    Chen, Canjian
    Lu, Xiaofeng
    JOURNAL OF BUON, 2020, 25 (02): : 627 - 633
  • [39] Reliability of Ki67-Labeling Index in Core Needle Biopsy Specimens of ER+/HER2-Breast Cancers
    Fukaya, Yumi
    Wakahara, Makoto
    Hosoya, Keiko
    Nouchi, Naoko
    Umekita, Yoshihisa
    PATHOLOGY INTERNATIONAL, 2025,
  • [40] Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR+/ HER2- breast cancer
    Hu, Jia
    Lv, Hong
    Zhao, Shen
    Lin, Cai-Jin
    Su, Guan-Hua
    Shao, Zhi-Ming
    JOURNAL OF THORACIC DISEASE, 2023, 15 (05) : 2528 - +